Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma.
Purpose To evaluate the apparent diffusion coefficients (ADCs) of magnetic resonance (MR) imaging patterns in the bone marrow of patients with multiple myeloma (MM) and to determine a threshold ADC that may help distinguish a diffuse from a normal pattern with high accuracy. Materials and Methods This prospective study was approved by the ethics review board, and informed consent was obtained. Ninety-nine patients with newly diagnosed, untreated MM and 16 healthy control subjects underwent spinal MR imaging including diffusion-weighted imaging, and bone marrow ADCs were calculated. Pattern assignment was based on visual assessment of conventional MR images. The Kruskal-Wallis H test, the Mann-Whitney test, and the one-way analysis of variance were used to compare ADCs between patient subsets and control subjects, and a receiver operating characteristic analysis was performed. Results Mean ADCs ± standard deviation in patients with MM for the normal, focal, and diffuse MR imaging patterns were 0.360 × 10-3mm2/sec ± 0.110, 1.046 × 10-3mm2/sec ± 0.232, and 0.770 × 10-3mm2/sec ± 0.135, respectively. There were significant differences in ADCs between diffuse and normal (P < .001), diffuse and focal (P < .001), and focal and normal (P < .001) patterns. Patients with a diffuse pattern had more features of advanced disease, higher international staging system score, increased incidence of high-risk cytogenetics, and higher revised international staging system score. ADCs greater than 0.548 × 10-3mm2/sec showed 100% sensitivity (26 of 26) and 98% specificity (48 of 49) for the diagnosis of a diffuse (vs normal) MR imaging pattern, whereas an ADC greater than 0.597 × 10-3mm2/sec showed 96% sensitivity (25 of 26) and 100% specificity (49 of 49). Conclusion ADCs of MR imaging patterns in patients with MM differ significantly. A diffuse MR imaging pattern can be distinguished more objectively from a normal MR imaging pattern by adding quantitative diffusion-weighted imaging to standard MR imaging protocols.©RSNA, 2016 Online supplemental material is available for this article.
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Vassilis
V
Koutoulidis
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Sophia
S
Fontara
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Evangelos
E
Terpos
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Flora
F
Zagouri
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Dimitris
D
Matsaridis
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Dimitrios
D
Christoulas
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Evangelia
E
Panourgias
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Efstathios
E
Kastritis
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Meletios A
MA
Dimopoulos
From the First Department of Radiology (V.K., S.F., D.M., E.P., L.A.M.) and Department of Clinical Therapeutics (E.T., F.Z., D.C., E.K., M.A.D.), School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, 76, Vas. Sophias Avenue, 11528 Athens, Greece.
Lia A
LA
Moulopoulos
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000000981:diagnostic imaging* / Q000473:pathology*; D016022:Case-Control Studies; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000473:pathology*; D011446:Prospective Studies